Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients

Chest

Volumn 114, Issue 2, 1998, Pages 380-387

  Braden, Gregory L ^a   Germain, Michael J ^b   Mulhern, Jeffrey G ^b   Hafer Jr , Jesse G ^b   Bria, William F ^b  

^a Baystate Med Cent   (United States)

^b NONE

Author keywords

Cardiac; Potassium; Terbutaline; adrenergic

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; INSULIN; TERBUTALINE SULFATE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; ELECTROLYTE BALANCE; GLUCOSE BLOOD LEVEL; HEART INDEX; HEMODYNAMICS; HOLTER MONITORING; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INSULIN BLOOD LEVEL; M MODE ECHOCARDIOGRAPHY; ORAL DRUG ADMINISTRATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0031812882     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.2.380     Document Type: Article

References (28)

1. Barrett TE, Strom BL. Inhaled beta-adrenergic receptor agonists in asthma: more harm than good? Am J Respir Care Med 1995; 151:574-77
2. 2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol 1994; 95:641-51
3. 2 agonists in the treatment of asthma? Chest 1995; 107:1116-24
4. Jenne JW, Tashkin DP. Beta-adrenergic agonists: physiology and pharmacology. In: Weiss EB, Stein M, eds. Bronchial asthma: mechanisms and therapeutics. Boston: Little Brown, 1993; 700-48
5. 2-agonist treatment. Am Rev Respir Dis 1993; 148:707-12
6. Carlstrom S, Westling H. Metabolic, circulatory and respiratory effects of a new sympathomimetic β-receptor-stimulating agent, terbutaline, compared with those of orciprenaline. Acta Med Scand 1970; 8512:33-40
7. Wong CS, Pavord ID, Williams J, et al. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990; 336:1396-99
8. Sessler CN, Ayres SM, Glauser FL. Cardiac interactions, arrhythmias, and pathology. In: Weiss EB, Stein M, eds. Bronchial asthma: mechanisms and therapeutics. Boston: Little Brown, 1993; 1045-53
9. Chapman KR, Smith DL, Rebuck AS, et al. Hemodynamic effects of an inhaled beta-2 agonist. Clin Pharmacol Ther 1984; 35:762-67
10. Kung M, White JR, Burki NK. The effect of subcutaneously administered terbutaline on serum potassium in asymptomatic adult asthmatics. Am Rev Respir Dis 1984; 129:329-32
11. Bengtsson B, Fagerstrom PO. Extrapulmonary effects of terbutaline during prolonged administration. Clin Pharmacol Ther 1982; 31:726-32
12. Cano A, Tovar I, Parrilla JJ, et al. Metabolic disturbances during intravenous use of ritodrine: increased insulin levels and hypokalemia. Obstet Gynecol 1984; 65:356-60
13. Hems DA, Whitton PD. Control of hepatic glycogenolysis. Physiol Rev 1980; 60:1-50
14. Sherwin RS, Sacca L. Effect of epinephrine on glucose metabolism in humans: contribution of the liver. Am J Physiol 1984; 247:E157-65
15. Schnack C, Podolsky A, Watzke H, et al. Effects of somatostatin and oral potassium administration on terbutaline-induced hypokalemia. Am Rev Respir Dis 1989; 139:176-80
16. 2-adrenergic stimulation with terbutaline in healthy subjects. Chest 1994; 106:1654-59
17. 2-receptor mediated? N Engl J Med 1985; 312:123-24
18. Bia MJ, Defronzo R. Regulation of extrarenal potassium homeostasis by adrenal hormones in rats. Am J Physiol 1982; 242:F641-49
19. Kuo SH, Kamaka JK, Lum BKB. Adrenergic receptor mechanisms involved in the hyperglycemia and hyperlactic-acidemia produced by sympathomimetic amines in the cat. J Pharmacol Exp Ther 1977; 202:301-09
20. Knapp WH. Relationships between mean velocity of circumferential fiber shortening and heart rate-the diagnostic value of a normalization of VCF to heart rate. JCU 1978; 6:10-15
21. Strauss MH, Reeves RA, Smith DL, et al. The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther 1986; 40:108-15
22. 2-agonist in humans. Circulation 1989; 79:107-15
23. Jenne JW, Chick TW, Strickland RD, et al. Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation. J Allergy Clin Immunol 1977; 59:383-90
24. Pierson DJ, Hudson LD, Stark K, et al. Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease. Chest 1980; 77:176-82
25. 2-receptor agonist specifically desensitizes β-receptor-mediated venodilation. Clin Pharmacol Ther 1993; 54:187-93
26. Zierler KL, Rabinowitz D. Effect of very small concentrations of insulin on forearm metabolism: persistence of its action on potassium and free fatty acids without its effect on glucose. J Clin Invest 1967; 43:950-62
27. Lipworth BJ, Clark RA, Dhillon DP, et al. Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 142:338-42
28. Lipworth BJ, Struthers AD, McDevitt DG. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis 1989; 140:586-92